Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Eastman Chemical Company (EMN) SEC filings page provides access to the company’s regulatory disclosures as a public issuer on the New York Stock Exchange. As a global specialty materials company in the plastics material and resin manufacturing industry, Eastman files periodic and current reports that describe its financial condition, results of operations, governance matters, and material events.
Among the most closely watched documents are annual reports on Form 10-K and quarterly reports on Form 10-Q, which include segment information, discussions of end-market demand in areas such as transportation, building and construction, and consumables, and commentary on topics like cash generation, cost structure, and specialty materials performance. Current reports on Form 8-K provide timely updates on specific events, including quarterly earnings releases, Board and executive changes, and other matters the company deems material.
Investors can also review proxy statements for information on Board composition, committee assignments, and director compensation, as well as filings related to executive compensation and governance. For those monitoring insider activity, Forms 3, 4, and 5 disclose transactions by directors and officers in Eastman’s common stock.
On this page, AI-powered tools summarize lengthy filings, highlight key sections, and help explain complex topics such as non-GAAP measures like adjusted EBIT and adjusted earnings per diluted share that Eastman discusses in its earnings materials. Real-time updates from the SEC’s EDGAR system ensure that new EMN filings, including 10-K, 10-Q, 8-K, and Form 4 submissions, are available quickly, allowing users to review the underlying disclosures and the AI-generated insights side by side.
Eastman Chemical Company reported an equity award to executive officer Stephen G. Crawford, EVP, Technology Projects. On 01/02/2026, he received 34,193 restricted stock units (RSUs), each representing a contingent right to receive one share of Eastman Chemical common stock. These RSUs were reported as derivative securities beneficially owned directly.
The RSUs carry a conversion price of $0 and are scheduled to vest and pay out in unrestricted shares of common stock on February 2, 2027, subject to Mr. Crawford’s continued employment. After this grant, he beneficially owns 34,193 derivative securities in the form of RSUs tied to Eastman Chemical common stock.
BlackRock, Inc. has filed an amended Schedule 13G reporting a significant passive ownership position in Eastman Chemical Co common stock. As of the event date of 11/30/2025, BlackRock reports beneficial ownership of 13,598,433 shares, representing 11.9% of Eastman Chemical’s outstanding common stock. BlackRock has sole voting power over 13,254,753 of these shares and sole dispositive power over all 13,598,433 shares, with no shared voting or dispositive power.
The filing is made on a passive basis, with BlackRock certifying the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Eastman Chemical. The filing notes that one underlying holder, iShares Core S&P Small-Cap ETF, has an interest in more than five percent of Eastman Chemical’s outstanding common stock.
Eastman Chemical (EMN) executive Stephen G. Crawford, EVP, Technology Projects, filed an initial statement of beneficial ownership. He reports 60,301 shares of common stock held directly, plus indirect holdings through retirement plans and spouse accounts.
He also lists employee stock options covering multiple grants, including 24,527 shares at $86.15 expiring 02/26/2034 and 25,883 shares at $83.84 expiring 02/23/2033. Vesting schedules note one‑third becoming exercisable on specified dates in 2025–2027 for recent grants.
Eastman Chemical (EMN) reported weaker Q3 2025 results. Sales were $2,202 million versus $2,464 million a year ago, and earnings before income taxes were $134 million versus $280 million. Net earnings were $47 million, with diluted EPS of $0.40 compared to $1.53.
Segment performance softened: total segment Adjusted EBIT was $249 million versus $407 million, with declines in Advanced Materials ($53 million vs $122 million), Chemical Intermediates ($1 million vs $43 million), and Fibers ($67 million vs $112 million). Additives & Functional Products was $128 million versus $130 million. The effective tax rate rose to 65%, reflecting impacts from the One Big Beautiful Bill Act and uncertain tax positions.
Year-to-date cash from operations was $468 million, capital expenditures $434 million, and net interest expense $156 million. Total borrowings were $5,075 million, including $290 million of commercial paper. Environmental reserves increased to $322 million. The company received $14 million of DOE reimbursements tied to a terminated grant related to the Longview, Texas recycling project.
Eastman Chemical Company reported that on November 3, 2025 it publicly released its financial results for third quarter 2025. The company made these results available through a press release that is furnished as Exhibit 99.01 to its current report. The information in the press release is treated as furnished, not filed, under the Securities Exchange Act of 1934 and is only incorporated into other securities filings if specifically referenced. The report is signed on behalf of Eastman Chemical Company by Michelle R. Stewart, Vice President, Chief Accounting Officer and Corporate Controller.
Damon J. Audia, a director of Eastman Chemical Co. (EMN), reported crediting of 1,360 phantom stock units on
The Form 4 was filed as a single reporting person filing and signed by power of attorney on
Eastman Chemical (EMN) director Renee J. Hornbaker reported an automatic deferral under the Directors' Deferred Compensation Plan. On 10/07/2025, she was credited with 487 phantom stock units (value equal to one share of common stock), at a price of $0, reflecting a portion of her annual retainer fees. Phantom units are payable only in cash after service as a director ends.
Following the transaction, she beneficially owned 49,781 derivative securities. This total includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.
Eastman Chemical (EMN) director Linnie M. Haynesworth reported acquiring 487 Phantom Stock Units on 10/07/2025 at $0, reflecting an automatic deferral of a portion of her annual director retainer into the Directors' Deferred Compensation Plan. After the transaction, she beneficially owns 3,559 phantom units. Each unit has a value equal to one share of common stock and is payable only in cash after her service as a director ends. The total includes 42 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents.
Director Eric L. Butler received 487 phantom stock units on
Insider filing for Eastman Chemical Co. (EMN) reports that director Julie Fasone received 487 phantom stock units under the Directors' Deferred Compensation Plan on 10/07/2025. These units mirror the market value of one share each and are payable only in cash after she leaves board service. The filing shows 14,377 common-stock-equivalent units beneficially owned after the transaction, which includes 324 units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units represent an automatic deferral of part of her annual retainer that would otherwise have been paid in cash. The filing was signed by a power of attorney on 10/09/2025.